|
|
|
|
LEADER |
01953nam a22003255i 4500 |
001 |
978-3-7643-8595-8 |
005 |
20191023212437.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 sz | s |||| 0|eng d |
020 |
|
|
|a 9783764385958
|
024 |
7 |
|
|a 10.1007/978-3-7643-8595-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Natural Compounds as Drugs, Volume II
|c edited by Frank Petersen, René Amstutz.
|
250 |
|
|
|a 1st ed. 2008.
|
260 |
# |
# |
|a Basel :
|b Birkhäuser Basel :
|b Imprint: Birkhäuser,
|c 2008.
|
300 |
|
|
|a X, 428 p. 212 illus., 27 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Progress in Drug Research,
|v 66
|
505 |
0 |
|
|a Activation of fungal silent gene clusters: A new avenue to drug discovery -- Total synthesis studies on macrocyclic pipecolic acid natural products: FK506, the antascomicins and rapamycin -- Application of natural product-inspired diversity-oriented synthesis to drug discovery -- Cheminformatics analysis of natural products: Lessons from nature inspiring the design of new drugs -- Chemical-genetic approaches for exploring the mode of action of natural products -- Epothilones as lead structures for new anticancer drugs - pharmacology, fermentation, and structure-activity-relationships -- Histone deacetylase inhibitors from microorganisms: the Astellas experience -- Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720 -- Artemisinin - an innovative cornerstone for anti-malaria therapy.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Biochemistry.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Biochemistry, general.
|
700 |
1 |
|
|a Petersen, Frank.
|e editor.
|
700 |
1 |
|
|a Amstutz, René.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-7643-8595-8
|